Works by Indelicato, Daniel J.


Results: 77
    1
    2
    3
    4
    5
    6
    7

    Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

    Published in:
    2020
    By:
    • Liu, Anthony P. Y.;
    • Gudenas, Brian;
    • Lin, Tong;
    • Orr, Brent A.;
    • Klimo, Paul;
    • Kumar, Rahul;
    • Bouffet, Eric;
    • Gururangan, Sridharan;
    • Crawford, John R.;
    • Kellie, Stewart J.;
    • Chintagumpala, Murali;
    • Fisher, Michael J.;
    • Bowers, Daniel C.;
    • Hassall, Tim;
    • Indelicato, Daniel J.;
    • Onar-Thomas, Arzu;
    • Ellison, David W.;
    • Boop, Frederick A.;
    • Merchant, Thomas E.;
    • Robinson, Giles W.
    Publication type:
    Correction Notice
    8

    Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

    Published in:
    Acta Neuropathologica, 2020, v. 139, n. 2, p. 259, doi. 10.1007/s00401-019-02106-9
    By:
    • Liu, Anthony P. Y.;
    • Gudenas, Brian;
    • Lin, Tong;
    • Orr, Brent A.;
    • Klimo, Paul;
    • Kumar, Rahul;
    • Bouffet, Eric;
    • Gururangan, Sridharan;
    • Crawford, John R.;
    • Kellie, Stewart J.;
    • Chintagumpala, Murali;
    • Fisher, Michael J.;
    • Bowers, Daniel C.;
    • Hassall, Tim;
    • Indelicato, Daniel J.;
    • Onar-Thomas, Arzu;
    • Ellison, David W.;
    • Boop, Frederick A.;
    • Merchant, Thomas E.;
    • Robinson, Giles W.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.

    Published in:
    Acta Oncologica, 2019, v. 58, n. 10, p. 1416, doi. 10.1080/0284186X.2019.1643496
    By:
    • Stokkevåg, Camilla H.;
    • Indelicato, Daniel J.;
    • Herfarth, Klaus;
    • Magelssen, Henriette;
    • Evensen, Morten E.;
    • Ugland, Maren;
    • Nordberg, Terje;
    • Nystad, Tove A.;
    • Hægeland, Camilla;
    • Alsaker, Mirjam D.;
    • Ulven, Kjetil;
    • Dale, Jon E.;
    • Engeseth, Grete M.;
    • Boer, Camilla G.;
    • Toussaint, Laura;
    • Kornerup, Josefine S.;
    • Pettersen, Helge E. S.;
    • Brydøy, Marianne;
    • Brandal, Petter;
    • Muren, Ludvig P.
    Publication type:
    Article
    17
    18
    19

    45 GyRBE for group III orbital embryonal rhabdomyosarcoma.

    Published in:
    Acta Oncologica, 2019, v. 58, n. 10, p. 1404, doi. 10.1080/0284186X.2019.1627412
    By:
    • Indelicato, Daniel J.;
    • Rotondo, Ronny L.;
    • Mailhot Vega, Raymond B.;
    • Uezono, Haruka;
    • Bradfield, Scott;
    • Agarwal, Vibhuti;
    • Hol, Marinka L.;
    • Bradley, Julie A.
    Publication type:
    Article
    20

    Clinical activity of pazopanib in metastatic extraosseous Ewing sarcoma.

    Published in:
    Rare Tumors, 2015, v. 7, n. 2, p. 86, doi. 10.4081/rt.2015.5992
    By:
    • Attia, Steven;
    • Okuno, Scott H.;
    • Robinson, Steven I.;
    • Webber, Nicholas P.;
    • Indelicato, Daniel J.;
    • Jones, Robin L.;
    • Bagaria, Sanjay P.;
    • Sherman, Courtney;
    • Kozak, Kevin R.;
    • Cortese, Cherise M.;
    • McFarland, Thomas;
    • Trent, Jonathan C.;
    • Maki, Robert G.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Outcomes following proton therapy for pediatric esthesioneuroblastoma.

    Published in:
    Pediatric Blood & Cancer, 2024, v. 71, n. 2, p. 1, doi. 10.1002/pbc.30793
    By:
    • Drescher, Nicolette R.;
    • Indelicato, Daniel J.;
    • Dagan, Roi;
    • Bradley, Julie A.;
    • Holtzman, Adam L.;
    • Mailhot Vega, Raymond B.;
    • Aldana, Philipp R.;
    • Sandler, Eric S.;
    • Morris, Christopher G.;
    • Mendenhall, William M.
    Publication type:
    Article
    26

    Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study.

    Published in:
    Pediatric Blood & Cancer, 2023, v. 70, n. 8, p. 1, doi. 10.1002/pbc.30412
    By:
    • Hol, Marinka L. F.;
    • Indelicato, Daniel J.;
    • Slater, Olga;
    • Kolb, Frederic;
    • Hewitt, Richard J;
    • Ong, Juling;
    • Becking, Alfred G.;
    • Gains, Jenny;
    • Bradley, Julie;
    • Sandler, Eric;
    • Gaze, Mark N.;
    • Pieters, Bradley;
    • Mandeville, Henry;
    • Fajardo, Raquel Dávila;
    • Schoot, Reineke;
    • Merks, Johannes H. M.;
    • Hammond, Peter;
    • Smeele, Ludwig E.;
    • Suttie, Michael
    Publication type:
    Article
    27
    28
    29
    30
    31
    32

    Endocrine dysfunction in long-term survivors of pediatric head and neck rhabdomyosarcoma.

    Published in:
    European Journal of Endocrinology, 2025, v. 192, n. 1, p. 25, doi. 10.1093/ejendo/lvae168
    By:
    • Morfouace, Michele;
    • Schoot, Reineke A;
    • Hol, Marinka L F;
    • Minard-Colin, Veronique;
    • Kolb, Frederic;
    • Bollé, Stephanie;
    • Kayembe, Matumba T;
    • Gaze, Mark N;
    • Sandler, Eric;
    • Knops, Rutger R G;
    • Merks, Johannes H M;
    • Smeele, Ludwig E;
    • Indelicato, Daniel J;
    • Slater, Olga;
    • Santen, Hanneke M van
    Publication type:
    Article
    33
    34

    Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).

    Published in:
    Journal of Neuro-Oncology, 2023, v. 162, n. 2, p. 353, doi. 10.1007/s11060-023-04296-5
    By:
    • Roehrig, Andrew;
    • Indelicato, Daniel J.;
    • Paulino, Arnold C.;
    • Ermoian, Ralph;
    • Hartsell, William;
    • Perentesis, John;
    • Hill-Kayser, Christine;
    • Lee, Jae Y.;
    • Laack, Nadia N.;
    • Mangona, Victor;
    • MacEwan, Iain;
    • Eaton, Bree R.;
    • Gallotto, Sara;
    • Bajaj, Benjamin V. M.;
    • Aridgides, Paul D.;
    • Yock, Torunn I.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42

    Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 557, doi. 10.1007/s11060-019-03129-8
    By:
    • Holtzman, Adam L.;
    • Rotondo, Ronny L.;
    • Rutenberg, Michael S.;
    • Indelicato, Daniel J.;
    • Mercado, Catherine E.;
    • Rao, Dinesh;
    • Tavanaiepour, Daryoush;
    • Morris, Christopher G.;
    • Louis, Debbie;
    • Flampouri, Stella;
    • Mendenhall, William M.
    Publication type:
    Article
    43
    44
    45
    46
    47

    Patient‐reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician‐graded adverse events—A multicenter study using the FACE‐Q Craniofacial module.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 4, p. 4739, doi. 10.1002/cam4.5252
    By:
    • Morfouace, Michèle;
    • Hol, Marinka L. F.;
    • Schoot, Reineke A.;
    • Slater, Olga;
    • Indelicato, Daniel J.;
    • Kolb, Frédéric;
    • Smeele, Ludwig E.;
    • Merks, Johannes H. M.;
    • Rae, Charlene;
    • Maurice‐Stam, Heleen;
    • Klassen, Anne F.;
    • Grootenhuis, Martha A.
    Publication type:
    Article
    48

    Outcomes following proton therapy for pediatric ependymoma.

    Published in:
    Acta Oncologica, 2018, v. 57, n. 5, p. 644, doi. 10.1080/0284186X.2017.1413248
    By:
    • Indelicato, Daniel J.;
    • Bradley, Julie A.;
    • Rotondo, Ronny L.;
    • Nanda, Ronica H.;
    • Logie, Natalie;
    • Morris, Christopher G.;
    • Mendenhall, Nancy P.;
    • Sandler, Eric S.;
    • Aldana, Philipp R.;
    • Ranalli, Nathan J.;
    • Beier, Alexandra D.
    Publication type:
    Article
    49
    50